Dipartimento di Scienze Biomediche Avanzate, Università Federico II, Via Pansini 5, 80131 Napoli, Italy Dipartimento di Medicina e Chirurgia, Università Degli Studi di Salerno, Via Salvador Allende, 84081 Baronissi, Italy IRCCS Multimedica, Via Fantoli 16/15, 20138 Milano, Italy
References Riferimenti: Kim, J.-A., Wei, Y., Sowers, J.R., Role of mitochondrial dysfunction in insulin resistance (2008) Circulation Research, 102 (4), pp. 401-414. , DOI 10.1161/CIRCRESAHA.107.165472, PII 000030122008022900000
Chance, B., Sies, H., Boveris, A., Hydroperoxide metabolism in mammalian organs (1979) Physiological Reviews, 59 (3), pp. 527-605
Evans, J.L., Goldfine, I.D., Maddux, B.A., Grodsky, G.M., Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes (2002) Endocrine Reviews, 23 (5), pp. 599-622. , DOI 10.1210/er.2001-0039
Carreras, M.C., Franco, M.C., Peralta, J.G., Poderoso, J.J., Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease (2004) Molecular Aspects of Medicine, 25 (1-2), pp. 125-139. , DOI 10.1016/j.mam.2004.02.014, PII S0098299704000159
Wallace, D.C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine (2005) Annual Review of Genetics, 39, pp. 359-407. , DOI 10.1146/annurev.genet.39.110304.095751
Green, K., Brand, M.D., Murphy, M.P., Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes (2004) Diabetes, 53 (SUPPL. 1), pp. S110-S118
Melov, S., Schneider, J.A., Day, B.J., Hinerfeld, D., Coskun, P., Mirra, S.S., Crapo, J.D., Wallace, D.C., A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase (1998) Nature Genetics, 18 (2), pp. 159-163. , DOI 10.1038/ng0298-159
James, A.M., Murphy, M.P., How mitochondrial damage affects cell function (2002) Journal of Biomedical Science, 9 (5-6), pp. 475-487
Sies, H., Strategies of antioxidant defense (1993) European Journal of Biochemistry, 215 (2), pp. 213-219
Pieczenik, S.R., Neustadt, J., Mitochondrial dysfunction and molecular pathways of disease (2007) Experimental and Molecular Pathology, 83 (1), pp. 84-92. , DOI 10.1016/j.yexmp.2006.09.008, PII S0014480006001328
Wei, Y.-H., Lu, C.-Y., Lee, H.-C., Pang, C.-Y., Ma, Y.-S., Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function (1998) Annals of the New York Academy of Sciences, 854, pp. 155-170. , DOI 10.1111/j.1749-6632.1998.tb09899.x
Duchen, M.R., Mitochondria in health and disease: Perspectives on a new mitochondrial biology (2004) Molecular Aspects of Medicine, 25 (4), pp. 365-451. , DOI 10.1016/j.mam.2004.03.001, PII S0098299704000366
Harper, M.-E., Bevilacqua, L., Hagopian, K., Weindruch, R., Ramsey, J.J., Ageing, oxidative stress, and mitochondrial uncoupling (2004) Acta Physiologica Scandinavica, 182 (4), pp. 321-331. , DOI 10.1111/j.1365-201X.2004.01370.x
Liu, J., Killilea, D.W., Ames, B.N., Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-α-lipoic acid (2002) Proceedings of the National Academy of Sciences of the United States of America, 99 (4), pp. 1876-1881. , DOI 10.1073/pnas.261709098
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., Namba, M., Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II (1998) Circulation, 98 (8), pp. 794-799
Suematsu, N., Tsutsui, H., Wen, J., Kang, D., Ikeuchi, M., Ide, T., Hayashidani, S., Takeshita, A., Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes (2003) Circulation, 107 (10), pp. 1418-1423. , DOI 10.1161/01.CIR.0000055318.09997.1F
Ames, B.N., Delaying the mitochondrial decay of aging (2004) Annals of the New York Academy of Sciences, 1019, pp. 406-411. , DOI 10.1196/annals.1297.073
Ames, B.N., Atamna, H., Killilea, D.W., Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging (2005) Molecular Aspects of Medicine, 26 (4-5 SPEC. ISS.), pp. 363-378. , DOI 10.1016/j.mam.2005.07.007, PII S0098299705000415
Atamna, H., Newberry, J., Erlitzki, R., Schultz, C.S., Ames, B.N., Biotin deficiency inhibits heme synthesis and impairs mitochondria in human lung fibroblasts (2007) Journal of Nutrition, 137 (1), pp. 25-30. , http://jn.nutrition.org/cgi/reprint/137/1/25
Atamna, H., Heme, iron, and the mitochondrial decay of ageing (2004) Ageing Research Reviews, 3 (3), pp. 303-318. , DOI 10.1016/j.arr.2004.02.002, PII S1568163704000121
Hu, F., Liu, F., Mitochondrial stress: A bridge between mitochondrial dysfunction and metabolic diseases? (2011) Cellular Signalling, 23 (10), pp. 1528-1533. , 2-s2.0-79960740086 10.1016/j.cellsig.2011.05.008
Bugger, H., Abel, E.D., Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome (2008) Clinical Science, 114 (3-4), pp. 195-210. , DOI 10.1042/CS20070166
Kelley, D.E., He, J., Menshikova, E.V., Ritov, V.B., Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes (2002) Diabetes, 51 (10), pp. 2944-2950. , 2-s2.0-0036788293
Wiederkehr, A., Wollheim, C.B., Minireview: Implication of mitochondria in insulin secretion and action (2006) Endocrinology, 147 (6), pp. 2643-2649. , http://endo.endojournals.org/cgi/reprint/147/6/2643, DOI 10.1210/en.2006-0057
Højlund, K., Mogensen, M., Sahlin, K., Beck-Nielsen, H., Mitochondrial dysfunction in type 2 diabetes and obesity (2008) Endocrinology and Metabolism Clinics of North America, 37 (3), pp. 713-731. , 2-s2.0-50449084335 10.1016/j.ecl.2008.06.006
Ashrafian, H., Frenneaux, M.P., Opie, L.H., Metabolic mechanisms in heart failure (2007) Circulation, 116 (4), pp. 434-448. , DOI 10.1161/CIRCULATIONAHA.107.702795, PII 0000301720070724000013
De Pauw, A., Tejerina, S., Raes, M., Keijer, J., Arnould, T., Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations (2009) The American Journal of Pathology, 175 (3), pp. 927-939. , 2-s2.0-70349240364 10.2353/ajpath.2009.081155
Lowell, B.B., Shulman, G.I., Mitochondrial dysfunction and type 2 diabetes (2005) Science, 307 (5708), pp. 384-387. , DOI 10.1126/science.1104343
Rong, J.X., Qiu, Y., Hansen, M.K., Zhu, L., Zhang, V., Xie, M., Okamoto, Y., Ryan, T.E., Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone (2007) Diabetes, 56 (7), pp. 1751-1760. , http://diabetes.diabetesjournals.org/cgi/reprint/56/7/1751, DOI 10.2337/db06-1135
Short, K.R., Bigelow, M.L., Kahl, J., Singh, R., Coenen-Schimke, J., Raghavakaimal, S., Nair, K.S., Decline in skeletal muscle mitochondrial function with aging in humans (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (15), pp. 5618-5623. , DOI 10.1073/pnas.0501559102
Dumas, J.-F., Simard, G., Flamment, M., Ducluzeau, P.-H., Ritz, P., Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans? (2009) Diabetes and Metabolism, 35 (3), pp. 159-167. , 2-s2.0-67349265189 10.1016/j.diabet.2009.02.002
Pagel-Langenickel, I., Bao, J., Pang, L., Sack, M.N., The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance (2010) Endocrine Reviews, 31 (1), pp. 25-51. , 2-s2.0-76149131004 10.1210/er.2009-0003
Fromenty, B., Pessayre, D., Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity (1995) Pharmacology and Therapeutics, 67 (1), pp. 101-154. , 2-s2.0-0029127584 10.1016/0163-7258(95)00012-6
Perez-Carreras, M., Del Hoyo, P., Martin, M.A., Rubio, J.C., Martin, A., Castellano, G., Colina, F., Solis-Herruzo, J.A., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis (2003) Hepatology, 38 (4), pp. 999-1007. , DOI 10.1053/jhep.2003.50398
Pessayre, D., Fromenty, B., NASH: A mitochondrial disease (2005) Journal of Hepatology, 42 (6), pp. 928-940. , DOI 10.1016/j.jhep.2005.03.004, PII S0168827805001704
Mitchell, C., Robin, M.-A., Mayeuf, A., Mahrouf-Yorgov, M., Mansouri, A., Hamard, M., Couton, D., Gilgenkrantz, H., Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice (2009) The American Journal of Pathology, 175 (5), pp. 1929-1937. , 2-s2.0-73649128871 10.2353/ajpath.2009.090332
Rossmeisl, M., Syrovy, I., Baumruk, F., Flachs, P., Janovska, P., Kopecky, J., Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue (2000) The FASEB Journal, 14 (12), pp. 1793-1800. , 2-s2.0-0033823015
He, W., Newman, J.C., Wang, M.Z., Ho, L., Verdin, E., Mitochondrial sirtuins: Regulators of protein acylation and metabolism (2012) Trends in Endocrinology and Metabolism, 23 (9), pp. 467-476
Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., Grueter, C.A., Verdin, E., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation (2010) Nature, 464 (7285), pp. 121-125. , 2-s2.0-77950806433 10.1038/nature08778
Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., Chang, Y., Sirtuin 3, a new target of PGC-1 α, plays an important role in the suppression of ROS and mitochondrial biogenesis (2010) PLoS ONE, 5 (7). , 2-s2.0-77955347446 10.1371/journal.pone.0011707 e11707
Reaven, G.M., The insulin resistance syndrome: Definition and dietary approaches to treatment (2005) Annual Review of Nutrition, 25, pp. 391-406. , DOI 10.1146/annurev.nutr.24.012003.132155
Gastaldi, G., Giacobino, J.-P., Ruiz, J., Metabolic syndrome, a mitochondrial desease? (2008) Revue Medicale Suisse, 4 (160), pp. 1387-1391
Ruderman, N.B., Carling, D., Prentki, M., Cacicedo, J.M., AMPK, insulin resistance, and the metabolic syndrome (2013) The Journal of Clinical Investigation, 123 (7), pp. 2764-2772
Maassen, J.A., 'T Hart, L.M., Van Essen, E., Heine, R.J., Nijpels, G., Jahangir Tafrechi, R.S., Raap, A.K., Lemkes, H.H.P.J., Mitochondrial diabetes: Molecular mechanisms and clinical presentation (2004) Diabetes, 53 (SUPPL. 1), pp. S103-S109
Morino, K., Petersen, K.F., Dufour, S., Befroy, D., Frattini, J., Shatzkes, N., Neschen, S., Shulman, G.I., Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents (2005) Journal of Clinical Investigation, 115 (12), pp. 3587-3593. , http://www.jci.org/cgi/reprint/115/12/3587, DOI 10.1172/JCI25151
Choksi, K.B., Boylston, W.H., Rabek, J.P., Widger, W.R., Papaconstantinou, J., Oxidatively damaged proteins of heart mitochondrial electron transport complexes (2004) Biochimica et Biophysica Acta - Molecular Basis of Disease, 1688 (2), pp. 95-101. , DOI 10.1016/j.bbadis.2003.11.007
Smith Jr., S.C., Multiple risk factors for cardiovascular disease and diabetes mellitus (2007) American Journal of Medicine, 120 (3 SUPPL. 1), pp. S3-S11. , DOI 10.1016/j.amjmed.2007.01.002, PII S0002934307000320, Modifying Cardiovascular and Metabolic Risk Factors: The Role of Endocannabinoid System and Cannabinoid Receptors
Cooper, S.A., Whaley-Connell, A., Habibi, J., Wei, Y., Lastra, G., Manrique, C., Stas, S., Sowers, J.R., Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance (2007) American Journal of Physiology - Heart and Circulatory Physiology, 293 (4), pp. H2009-H2023. , http://ajpheart.physiology.org/cgi/reprint/293/4/H2009, DOI 10.1152/ajpheart.00522.2007
Sowers, J.R., Insulin resistance and hypertension (2004) American Journal of Physiology - Heart and Circulatory Physiology, 286 (5), pp. H1597-H1602. , DOI 10.1152/ajpheart.00026.2004
Bach, D., Pich, S., Soriano, F.X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J.R., Zorzano, A., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: A novel regulatory mechanism altered in obesity (2003) Journal of Biological Chemistry, 278 (19), pp. 17190-17197. , DOI 10.1074/jbc.M212754200
Walder, K., Kerr-Bayles, L., Civitarese, A., Jowett, J., Curran, J., Elliott, K., Trevaskis, J., Collier, G.R., The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes (2005) Diabetologia, 48 (3), pp. 459-468. , DOI 10.1007/s00125-005-1675-9
Cantó, C., Auwerx, J., PGC-1 α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure (2009) Current Opinion in Lipidology, 20 (2), pp. 98-105. , 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
Mensink, M., Hesselink, M.K.C., Russell, A.P., Schaart, G., Sels, J.-P., Schrauwen, P., Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus (2007) International Journal of Obesity, 31 (8), pp. 1302-1310. , DOI 10.1038/sj.ijo.0803567, PII 0803567
Mootha, V.K., Lindgren, C.M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Groop, L.C., PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes (2003) Nature Genetics, 34 (3), pp. 267-273. , DOI 10.1038/ng1180
Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M.A., Brownlee, M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (2000) Nature, 404 (6779), pp. 787-790. , DOI 10.1038/35008121
Yamagishi, S.-I., Edelstein, D., Du, X.-L., Kaneda, Y., Guzmán, M., Brownlee, M., Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A (2001) Journal of Biological Chemistry, 276 (27), pp. 25096-25100. , 2-s2.0-0035816639 10.1074/jbc.M007383200
Boss, O., Hagen, T., Lowell, B.B., Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism (2000) Diabetes, 49 (2), pp. 143-156
Krebs, M., Roden, M., Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature (2005) Diabetes, Obesity and Metabolism, 7 (6), pp. 621-632. , DOI 10.1111/j.1463-1326.2004.00439.x
Houstis, N., Rosen, E.D., Lander, E.S., Reactive oxygen species have a causal role in multiple forms of insulin resistance (2006) Nature, 440 (7086), pp. 944-948. , 2-s2.0-33645860825 10.1038/nature04634
Reaven, G.M., Chen, Y.-D.I., Insulin resistance, its consequences, and coronary heart disease: Must we choose one culprit (1996) Circulation, 93 (10), pp. 1780-1783
Kostis, J.B., Sanders, M., The association of heart failure with insulin resistance and the development of type 2 diabetes (2005) American Journal of Hypertension, 18 (5), pp. 731-737. , DOI 10.1016/j.amjhyper.2004.11.038, PII S0895706104011938
Boudina, S., Sena, S., O'Neill, B.T., Tathireddy, P., Young, M.E., Abel, E.D., Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity (2005) Circulation, 112 (17), pp. 2686-2695. , DOI 10.1161/CIRCULATIONAHA.105.554360
Szczepaniak, L.S., Dobbins, R.L., Metzger, G.J., Sartoni-D'Ambrosia, G., Arbique, D., Vongpatanasin, W., Unger, R., Victor, R.G., Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging (2003) Magnetic Resonance in Medicine, 49 (3), pp. 417-423. , DOI 10.1002/mrm.10372
Christoffersen, C., Bollano, E., Lindegaard, M.L.S., Bartels, E.D., Goetze, J.P., Andersen, C.B., Nielsen, L.B., Cardiac lipid accumulation associated with diastolic dysfunction in obese mice (2003) Endocrinology, 144 (8), pp. 3483-3490. , DOI 10.1210/en.2003-0242
Seyfried, T.N., Shelton, L.M., Cancer as a metabolic disease (2010) Nutrition and Metabolism, 77. , 2-s2.0-77649277719 10.1186/1743-7075-7-7
Kwong, J.Q., Henning, M.S., Starkov, A.A., Manfredi, G., The mitochondrial respiratory chain is a modulator of apoptosis (2007) Journal of Cell Biology, 179 (6), pp. 1163-1177. , http://www.jcb.org/cgi/reprint/179/6/1163, DOI 10.1083/jcb.200704059
Wu, Y.-T., Wu, S.-B., Lee, W.-Y., Wei, Y.-H., Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases (2010) Annals of the New York Academy of Sciences, 1201, pp. 147-156. , 2-s2.0-77955291455 10.1111/j.1749-6632.2010.05631.x
John, A.P., Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: The impact of this on the treatment of cancer (2001) Medical Hypotheses, 57 (4), pp. 429-431. , DOI 10.1054/mehy.2001.1335
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Kroemer, G., Mitochondrial gateways to cancer (2010) Molecular Aspects of Medicine, 31 (1), pp. 1-20. , 2-s2.0-77649338652 10.1016/j.mam.2009.08.002
Foster, C.S., Spoerri, P.E., Glees, P., Spoerri, O., The mode of mitochondrial degeneration in gliomas (1978) Acta Neurochirurgica, 43 (3-4), pp. 229-237
Rasmussen, A.K., Chatterjee, A., Rasmussen, L.J., Singh, K.K., Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae (2003) Nucleic Acids Research, 31 (14), pp. 3909-3917. , DOI 10.1093/nar/gkg446
Cuezva, J.M., Krajewska, M., De Heredia, M.L., Krajewski, S., Santamaria, G., Kim, H., Zapata, J.M., Reed, J.C., The bioenergetic signature of cancer: A marker of tumor progression (2002) Cancer Research, 62 (22), pp. 6674-6681
Pelicano, H., Lu, W., Zhou, Y., Zhang, W., Chen, Z., Hu, Y., Huang, P., Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism (2009) Cancer Research, 69 (6), pp. 2375-2383. , 2-s2.0-65549142759 10.1158/0008-5472.CAN-08-3359
Zhu, X., Peng, X., Guan, M.-X., Yan, Q., Pathogenic mutations of nuclear genes associated with mitochondrial disorders (2009) Acta Biochimica et Biophysica Sinica, 41 (3), pp. 179-187. , 2-s2.0-65249092667 10.1093/abbs/gmn021
Altenberg, B., Greulich, K.O., Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes (2004) Genomics, 84 (6), pp. 1014-1020. , DOI 10.1016/j.ygeno.2004.08.010, PII S0888754304002277
Warburg, O., On the origin of cancer cells (1956) Science, 123 (3191), pp. 309-314. , 2-s2.0-12444279265
Osthus, R.C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Dang, C.V., Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc (2000) Journal of Biological Chemistry, 275 (29), pp. 21797-21800. , DOI 10.1074/jbc.C000023200
Flier, J.S., Mueckler, M.M., Usher, P., Lodish, H.F., Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes (1987) Science, 235 (4795), pp. 1492-1495
Shim, H., Dolde, C., Lewis, B.C., Wu, C.-S., Dang, G., Jungmann, R.A., Dalla-Favera, R., Dang, C.V., C-Myc transactivation of LDH-A: Implications for tumor metabolism and growth (1997) Proceedings of the National Academy of Sciences of the United States of America, 94 (13), pp. 6658-6663. , DOI 10.1073/pnas.94.13.6658
Salem, A.F., Whitaker-Menezes, D., Lin, Z., Martinez-Outschoorn, U.E., Tanowitz, H.B., Al-Zoubi, M.S., Howell, A., Lisanti, M.P., Two-compartment tumor metabolism: Autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells Cell Cycle, 11 (13), pp. 2545-2556
Balliet, R.M., Capparelli, C., Guido, C., Pestell, T.G., Martinez-Outschoorn, U.E., Lin, Z., Whitaker-Menezes, D., Lisanti, M.P., Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: Understanding the aging and cancer connection (2011) Cell Cycle, 10 (23), pp. 4065-4073. , 2-s2.0-82855170859 10.4161/cc.10.23.18254
Henze, A.-T., Acker, T., Feedback regulators of hypoxia-inducible factors and their role in cancer biology (2010) Cell Cycle, 9 (14), pp. 2749-2763. , 2-s2.0-77956805884 10.4161/cc.9.14.12249
Hockel, M., Vaupel, P., Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects (2001) Journal of the National Cancer Institute, 93 (4), pp. 266-276
Amelio, I., Melino, G., The "sharp" blade against HIF-mediated metastasis Cell Cycle, 11 (24), pp. 4530-4535
Briston, T., Yang, J., Ashcroft, M., HIF-1 α localization with mitochondria: A new role for an old favorite? (2011) Cell Cycle, 10 (23), pp. 4170-4171. , 2-s2.0-82855181978 10.4161/cc.10.23.18565
Bertozzi, D., Iurlaro, R., Sordet, O., Marinello, J., Zaffaroni, N., Capranico, G., Characterization of novel antisense HIF-1 α transcripts in human cancers (2011) Cell Cycle, 10 (18), pp. 3189-3197. , 2-s2.0-80052885284 10.4161/cc.10.18.17183
Rapisarda, A., Shoemaker, R.H., Melillo, G., Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads (2009) Cell Cycle, 8 (24), pp. 4040-4043. , 2-s2.0-74849127957
Maxwell, P.H., HIF-1's relationship to oxygen: Simple yet sophisticated (2004) Cell Cycle, 3 (2), pp. 156-159
Ma, J., Zhang, Q., Chen, S., Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species (2013) PLoS ONE, 8 (7). , e69485
Compton, S., Kim, C., Griner, N.B., Potluri, P., Scheffler, I.E., Sen, S., Jerry, D.J., Yadava, N., Mitochondrial dysfunction impairs tumor suppressor p53 expression/function (2011) Journal of Biological Chemistry, 286 (23), pp. 20297-20312. , 2-s2.0-79957994581 10.1074/jbc.M110.163063
Schwartzenberg-Bar-Yoseph, F., Armoni, M., Karnieli, E., The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression (2004) Cancer Research, 64 (7), pp. 2627-2633. , DOI 10.1158/0008-5472.CAN-03-0846
Szatrowski, T.P., Nathan, C.F., Production of large amounts of hydrogen peroxide by human tumor cells (1991) Cancer Research, 51 (3), pp. 794-798. , 2-s2.0-0026021362
Moreno-Sanchez, R., Rodriguez-Enriquez, S., Marin-Hernandez, A., Saavedra, E., Energy metabolism in tumor cells (2007) FEBS Journal, 274 (6), pp. 1393-1418. , DOI 10.1111/j.1742-4658.2007.05686.x
Pelicano, H., Martin, D.S., Xu, R.-H., Huang, P., Glycolysis inhibition for anticancer treatment (2006) Oncogene, 25 (34), pp. 4633-4646. , DOI 10.1038/sj.onc.1209597, PII 1209597
Bauer, G., Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling Anticancer Research, 32 (7), pp. 2599-2624
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Hayashi, J.-I., ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis (2008) Science, 320 (5876), pp. 661-664. , DOI 10.1126/science.1156906
Carew, J.S., Zhou, Y., Albitar, M., Carew, J.D., Keating, M.J., Huang, P., Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: Clinical significance and therapeutic implications (2003) Leukemia, 17 (8), pp. 1437-1447. , DOI 10.1038/sj.leu.2403043
Indo, H.P., Davidson, M., Yen, H.-C., Suenaga, S., Tomita, K., Nishii, T., Higuchi, M., Majima, H.J., Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage (2007) Mitochondrion, 7 (1-2), pp. 106-118. , DOI 10.1016/j.mito.2006.11.026, PII S1567724906002248, Mitochondria and Life
Tan, D.-J., Bai, R.-K., Wong, L.-J.C., Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer (2002) Cancer Research, 62 (4), pp. 972-976
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J.K.V., Markowitz, S.D., Trush, M.A., Vogelstein, B., Somatic mutations of the mitochondrial genome in human colorectal tumours (1998) Nature Genetics, 20 (3), pp. 291-293. , DOI 10.1038/3108
Liu, V.W.S., Hong Hui Shi, Cheung, A.N.Y., Pui Man Chiu, Tsin Wah Leung, Nagley, P., Ling Wong Wong, Ngan, H.Y.S., High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas (2001) Cancer Research, 61 (16), pp. 5998-6001
Sanchez-Cespedes, M., Parrella, P., Nomoto, S., Cohen, D., Xiao, Y., Esteller, M., Jeronimo, C., Sidransky, D., Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors (2001) Cancer Research, 61 (19), pp. 7015-7019
Fliss, M.S., Usadel, H., Caballero, O.L., Wu, L., Buta, M.R., Eleff, S.M., Jen, J., Sidransky, D., Facile detection of mitochondrial DNA mutations in tumors and bodily fluids (2000) Science, 287 (5460), pp. 2017-2019. , DOI 10.1126/science.287.5460.2017
Reed, J.C., Molecular biology of chronic lymphocytic leukemia (1998) Seminars in Oncology, 25 (1), pp. 11-18
Sharief, M.K., Douglas, M., Noori, M., Semra, Y.K., The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis (2002) Journal of Neuroimmunology, 125 (1-2), pp. 155-162. , DOI 10.1016/S0165-5728(02)00024-3, PII S0165572802000243
Heiser, D., Labi, V., Erlacher, M., Villunger, A., The Bcl-2 protein family and its role in the development of neoplastic disease (2004) Experimental Gerontology, 39 (8), pp. 1125-1135. , DOI 10.1016/j.exger.2004.04.011, PII S0531556504001822
Takeuchi, O., Fisher, J., Suh, H., Harada, H., Malynn, B.A., Korsmeyer, S.J., Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (32), pp. 11272-11277. , DOI 10.1073/pnas.0504783102
Traver, D., Akashi, K., Weissman, I.L., Lagasse, E., Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia (1998) Immunity, 9 (1), pp. 47-57. , DOI 10.1016/S1074-7613(00)80587-7
Schumacher, B., Hofmann, K., Boulton, S., Gartner, A., The C. Elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis (2001) Current Biology, 11 (21), pp. 1722-1727. , DOI 10.1016/S0960-9822(01)00534-6
Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Sinclair, D.A., Resveratrol improves health and survival of mice on a high-calorie diet (2006) Nature, 444 (7117), pp. 337-342. , DOI 10.1038/nature05354, PII NATURE05354
Pearson, K.J., Baur, J.A., Lewis, K.N., Peshkin, L., Price, N.L., Labinskyy, N., Swindell, W.R., De Cabo, R., Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span (2008) Cell Metabolism, 8 (2), pp. 157-168. , 2-s2.0-48349144852 10.1016/j.cmet.2008.06.011
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Auwerx, J., Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α (2006) Cell, 127 (6), pp. 1109-1122. , DOI 10.1016/j.cell.2006.11.013, PII S0092867406014280
Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L., Westphal, C.H., Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes (2007) Nature, 450 (7170), pp. 712-716. , DOI 10.1038/nature06261, PII NATURE06261
Winder, W.W., Holmes, B.F., Rubink, D.S., Jensen, E.B., Chen, M., Holloszy, J.O., Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle (2000) Journal of Applied Physiology, 88 (6), pp. 2219-2226
Fujii, N., Jessen, N., Goodyear, L.J., AMP-activated protein kinase and the regulation of glucose transport (2006) The American Journal of Physiology, 291 (5), pp. E867-E877. , 2-s2.0-33751195101 10.1152/ajpendo.00207.2006
Ruderman, N.B., Saha, A.K., Kraegen, E.W., Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity (2003) Endocrinology, 144 (12), pp. 5166-5171. , DOI 10.1210/en.2003-0849
Mayers, R.M., Leighton, B., Kilgour, E., PDH kinase inhibitors: A novel therapy for Type II diabetes? (2005) Biochemical Society Transactions, 33 (2), pp. 367-370. , DOI 10.1042/BST0330367
Yorek, M.A., The role of oxidative stress in diabetic vascular and neural disease (2003) Free Radical Research, 37 (5), pp. 471-480. , DOI 10.1080/1071576031000083161
Maguire, J.J., Wilson, D.S., Packer, L., Mitochondrial electron transport-linked tocopheroxyl radical reduction (1989) Journal of Biological Chemistry, 264 (36), pp. 21462-21465
Yi, X., Maeda, N., α-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet (2006) Diabetes, 55 (8), pp. 2238-2244. , http://diabetes.diabetesjournals.org/cgi/content/full/55/8/2238, DOI 10.2337/db06-0251
Mehta, K., Van Thiel, D.H., Shah, N., Mobarhan, S., Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants (2002) Nutrition Reviews, 60 (9), pp. 289-293. , DOI 10.1301/002966402320387224
Li, M., Peterson, S., Husney, D., Inaba, M., Guo, K., Eri, T., Morita, T., Abraham, N.G., Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: Possible role of carbon monoxide and bilirubin (2007) Antioxidants and Redox Signaling, 9 (7), pp. 855-863. , DOI 10.1089/ars.2007.1568
Kelso, G.F., Porteous, C.M., Coulter, C.V., Hughes, G., Porteous, W.K., Ledgerwood, E.C., Smith, R.A.J., Murphy, M.P., Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties (2001) Journal of Biological Chemistry, 276 (7), pp. 4588-4596. , 2-s2.0-0035895888 10.1074/jbc.M009093200
Adlam, V.J., Harrison, J.C., Porteous, C.M., James, A.M., Smith, R.A.J., Murphy, M.P., Sammut, I.A., Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury (2005) FASEB Journal, 19 (9), pp. 1088-1095. , DOI 10.1096/fj.05-3718com
Jauslin, M.L., Meier, T., Smith, R.A., Murphy, M.P., Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants (2003) The FASEB Journal, 17 (13), pp. 1972-1974
Saretzki, G., Murphy, M.P., Von Zglinicki, T., MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress (2003) Aging Cell, 2 (2), pp. 141-143. , 2-s2.0-0041419866
Dhanasekaran, A., Kotamraju, S., Kalivendi, S.V., Matsunaga, T., Shang, T., Keszler, A., Joseph, J., Kalyanaraman, B., Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis (2004) Journal of Biological Chemistry, 279 (36), pp. 37575-37587. , DOI 10.1074/jbc.M404003200
Schafer, M., Schafer, C., Ewald, N., Piper, H.M., Noll, T., Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia (2003) Circulation Research, 92 (9), pp. 1010-1015. , DOI 10.1161/01.RES.0000070882.81508.FC
Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., Nathan, D.M., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (2002) New England Journal of Medicine, 346 (6), pp. 393-403. , DOI 10.1056/NEJMoa012512
Henriksen, E.J., Invited review: Effects of acute exercise and exercise training on insulin resistance (2002) Journal of Applied Physiology, 93 (2), pp. 788-796
Reznick, R.M., Shulman, G.I., The role of AMP-activated protein kinase in mitochondrial biogenesis (2006) Journal of Physiology, 574 (1), pp. 33-39. , DOI 10.1113/jphysiol.2006.109512
Röckl, K.S.C., Witczak, C.A., Goodyear, L.J., Signaling mechanisms in skeletal muscle: Acute responses and chronic adaptations to exercise (2008) IUBMB Life, 60 (3), pp. 145-153. , 2-s2.0-44049092767 10.1002/iub.21
Fulda, S., Exploiting mitochondrial apoptosis for the treatment of cancer (2010) Mitochondrion, 10 (6), pp. 598-603. , 2-s2.0-78149359030 10.1016/j.mito.2010.05.001
Hagland, H., Nikolaisen, J., Hodneland, L.I., Gjertsen, B.T., Bruserud, O., Tronstad, K.J., Targeting mitochondria in the treatment of human cancer: A coordinated attack against cancer cell energy metabolism and signalling (2007) Expert Opinion on Therapeutic Targets, 11 (8), pp. 1055-1069. , DOI 10.1517/14728222.11.8.1055
Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C.T., Michelakis, E.D., A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth (2007) Cancer Cell, 11 (1), pp. 37-51. , DOI 10.1016/j.ccr.2006.10.020, PII S1535610806003722
Schulz, T.J., Thierbach, R., Voigt, A., Drewes, G., Mietzner, B., Steinberg, P., Pfeiffer, A.F.H., Ristow, M., Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited (2006) Journal of Biological Chemistry, 281 (2), pp. 977-981. , 2-s2.0-33644868755 10.1074/jbc.M511064200
Holinger, E.P., Chittenden, T., Lutz, R.J., Bak BH3 peptides antagonize Bcl-x(L) function and induce apoptosis through cytochrome c-independent activation of caspases (1999) Journal of Biological Chemistry, 274 (19), pp. 13298-13304. , DOI 10.1074/jbc.274.19.13298
Targeting mitochondria as therapeutic strategy for metabolic disorders
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(227 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(237 visite) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 DettagliEsporta in BibTeXEsporta in EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(302 visite) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 DettagliEsporta in BibTeXEsporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(570 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(467 visite) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 DettagliEsporta in BibTeXEsporta in EndNote
264 Records (239 escludendo Abstract e Conferenze). Impact factor totale: 1166.628 (1084.834 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1180.713 (1088.94 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:52 471 views visite. Last view on Ultima visita in data Sunday 28 March 2021, 3:19:46